Xizang Haisco Pharmaceutical Group Co Ltd - Asset Resilience Ratio

Latest as of March 2026: 1.70%

Xizang Haisco Pharmaceutical Group Co Ltd (002653) has an Asset Resilience Ratio of 1.70% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

CN¥130.00 Million

≈ $19.02 Million USD Cash + Short-term Investments

Total Assets

CN¥7.66 Billion

≈ $1.12 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2008–2024)

This chart shows how Xizang Haisco Pharmaceutical Group Co Ltd's Asset Resilience Ratio has changed over time. Check asset allocation strategy of Xizang Haisco Pharmaceutical Group Co Lt to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Xizang Haisco Pharmaceutical Group Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Xizang Haisco Pharmaceutical Group Co Lt stock valuation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥130.00 Million	1.7%
Total Liquid Assets	CN¥130.00 Million	1.70%

Asset Resilience Insights

Limited Liquidity: Xizang Haisco Pharmaceutical Group Co Ltd maintains only 1.70% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Xizang Haisco Pharmaceutical Group Co Ltd Industry Peers by Asset Resilience Ratio

Compare Xizang Haisco Pharmaceutical Group Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Ascendis Pharma AS NASDAQ:ASND	Biotechnology	0.00%
Halozyme Therapeutics Inc NASDAQ:HALO	Biotechnology	12.71%
Akero Therapeutics Inc NASDAQ:AKRO	Biotechnology	55.87%
Beijing Tiantan Biological Products Corp Ltd SHG:600161	Biotechnology	8.08%
Zealand Pharma A/S CO:ZEAL	Biotechnology	63.98%
Verona Pharma PLC ADR NASDAQ:VRNA	Biotechnology	0.00%
Immunitybio Inc NASDAQ:IBRX	Biotechnology	38.07%
Tibet Cheezheng Tibetan Medicine Co Ltd SHE:002287	Biotechnology	37.31%

Annual Asset Resilience Ratio for Xizang Haisco Pharmaceutical Group Co Ltd (2008–2024)

The table below shows the annual Asset Resilience Ratio data for Xizang Haisco Pharmaceutical Group Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	2.21%	CN¥150.13 Million ≈ $21.97 Million	CN¥6.80 Billion ≈ $994.82 Million	-0.20pp
2023-12-31	2.41%	CN¥160.06 Million ≈ $23.42 Million	CN¥6.65 Billion ≈ $973.53 Million	+5.77pp
2022-12-31	-3.36%	CN¥-203.16 Million ≈ $-29.73 Million	CN¥6.05 Billion ≈ $884.95 Million	+0.30pp
2021-12-31	-3.66%	CN¥-183.34 Million ≈ $-26.83 Million	CN¥5.01 Billion ≈ $732.43 Million	-11.07pp
2020-12-31	7.41%	CN¥370.32 Million ≈ $54.19 Million	CN¥5.00 Billion ≈ $731.65 Million	+0.84pp
2019-12-31	6.56%	CN¥330.47 Million ≈ $48.36 Million	CN¥5.04 Billion ≈ $736.82 Million	-2.16pp
2018-12-31	8.73%	CN¥380.99 Million ≈ $55.75 Million	CN¥4.37 Billion ≈ $638.86 Million	+6.90pp
2017-12-31	1.83%	CN¥75.10 Million ≈ $10.99 Million	CN¥4.11 Billion ≈ $601.25 Million	+1.69pp
2016-12-31	0.13%	CN¥5.00 Million ≈ $731.66K	CN¥3.74 Billion ≈ $547.80 Million	+0.24pp
2015-12-31	-0.11%	CN¥-3.45 Million ≈ $-504.87K	CN¥3.23 Billion ≈ $472.29 Million	-35.76pp
2014-12-31	35.65%	CN¥1.02 Billion ≈ $149.99 Million	CN¥2.87 Billion ≈ $420.69 Million	+22.22pp
2013-12-31	13.43%	CN¥330.00 Million ≈ $48.29 Million	CN¥2.46 Billion ≈ $359.56 Million	+13.48pp
2012-12-31	-0.05%	CN¥-977.11K ≈ $-142.98K	CN¥1.95 Billion ≈ $284.80 Million	--
2008-12-31	0.00%	CN¥0.00 ≈ $0.00	CN¥353.69 Million ≈ $51.76 Million	--

pp = percentage points

About Xizang Haisco Pharmaceutical Group Co Ltd

SHE:002653 China Biotechnology

Market Cap

$10.22 Billion

CN¥69.86 Billion CNY

Market Cap Rank

#2185 Global

#228 in China

Share Price

CN¥62.38

Change (1 day)

+3.88%

52-Week Range

CN¥42.93 - CN¥79.19

All Time High

CN¥79.19